InvestorsHub Logo

endlich0

07/20/16 6:45 PM

#66442 RE: Cycle40 #66441

Thank you for Clearing that ! That is exactly what i hoped!

Krysti

07/21/16 5:26 AM

#66443 RE: Cycle40 #66441

A REVO extension patent was issued to Eyetalk365.

Ron Carter is shown as the inventor of the improvements, but the patent has been issued to Eyetalk365.

This means that Ron Carter now works for Eyetalk, and not REVO.

Which means that REVO shareholders will see as much from this patent as they have seen from the others.

The grand total of royalties REVO has received from Eyetalk365 is $nil. $nothing. $nichts....

...As Eyetalk is, presumably, receiving money from royalties.

That doesn't sound like a 60:40 split.

Something smell fishy to you?

SamuraiAnimated

07/21/16 11:02 AM

#66444 RE: Cycle40 #66441

If REVO goes out of business or gets removed from the stock market, then what happnes to REVO patents? Or more specifically, what happens to your investment in their patents?

Eyetalk will mean nothing to your REVO investment if they do not continue existence. REVO has proven to me they have no intent of remaining a public company.